Table 1

Baseline Characteristics of Participants

Clinical characteristics
 Gender (M/F)23 (46.9)/26 (53.1)
 Age, yrs60.6 ± 11.5
 BMI, kg/m228.0 ± 5.9
 Duration of AF, months63.9 ± 71.9
 Symptomatic AF43 (87.7)
 LV ejection fraction, %58.5 ± 6.3
 LA size, cm4.01 ± 0.50
Comorbid conditions
 Coronary artery disease9 (18.4)
 Diabetes mellitus1 (2.0)
 Hypertension19 (38.8)
 Hyperlipidemia20 (40.8)
 Obstructive sleep apnea11 (22.4)
 Prior revascularization (PCI/CABG)4 (8.2)
Medication use
 Aspirin28 (57.1)
 Beta-blockers31 (63.3)
 ACE-I/ARB10 (20.4)
 Statins16 (32.7)
 Antiarrhythmic medications38 (77.6)

Values are n (%) or mean ± SD.

ACE-I = angiotensin-converting enzyme inhibitor; AF = atrial fibrillation; ARB = angiotensin receptor blocker; BMI = body mass index; CABG = coronary artery bypass grafting surgery; LA = left atrium; LV = left ventricular; PCI = percutaneous coronary intervention.